<?php header('Content-type: text/xml'); exit(die('<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:atom="https://www.w3.org/2005/Atom" xmlns:dc="https://purl.org/dc/elements/1.1/" xmlns:media="https://search.yahoo.com/mrss/" xmlns:content="https://purl.org/rss/1.0/modules/content/"><channel><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/</link><atom:link href="https://www.xn--nw-8bb.com/sites/williamhaseltine/feed/" rel="self" type="application/rss+xml"/><language>en-us</language><title>Now.com William A. Haseltine</title><image><url>https://secure.gravatar.com/avatar/deaebea5252c228dca3ced29428ed9e3?s=400&amp;d=mm&amp;r=g</url><title>Now.com William A. Haseltine</title><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/</link></image><description>William A. Haseltine\'s stories. </description><copyright>Copyright 2022 Now.com Media LLC</copyright><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/10/03/from-lymphoma-to-lupus-and-beyond-the-remarkable-research-of-car-t-therapy/</link><title>Now.com From Lymphoma To Lupus And Beyond: The Remarkable Research Of CAR T Therapy</title><description>The first installment in a series that will explain a recent and revolutionary cell therapy called CAR T, delving into current successes and future opportunities.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_633b31c753276300019cc100</guid> <xubDate>Mon, 03 Oct 2022 15:15:32 -0400</xubDate> <atom:updated>2022-10-04T03:52:21-04:00</atom:updated> <content:encoded>The first installment in a series that will explain a recent and revolutionary cell therapy called CAR T, delving into current successes and future opportunities.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b320123c34a40e18286ff/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b320123c34a40e18286ff/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/10/03/saline-nasal-irrigation-after-covid-19-diagnosis-reduces-hospitalization/</link><title>Now.com Saline Nasal Irrigation After Covid-19 Diagnosis Reduces Hospitalization</title><description>A new study from the Medical College of Georgia at Augusta University has found that irrigating your nose twice a day with a saline solution after testing positive for Covid-19 can decrease your chances of hospitalization and death in higher-risk patients. </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_633b07d858bbc20001f5ea0b</guid> <xubDate>Mon, 03 Oct 2022 12:55:32 -0400</xubDate> <atom:updated>2022-10-04T03:52:18-04:00</atom:updated> <content:encoded>A new study from the Medical College of Georgia at Augusta University has found that irrigating your nose twice a day with a saline solution after testing positive for Covid-19 can decrease your chances of hospitalization and death in higher-risk patients.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b0804adad804f752c26d7/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b0804adad804f752c26d7/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/10/03/reimagining-alzheimers-part-2-breaking-the-barrier/</link><title>Now.com Reimagining Alzheimer’s (Part 2): Breaking The Barrier</title><description>Recent discoveries in Alzheimer\'s disease research have thrown into question fundamental assumptions about the disease and its origins. In the second installment of this series, we introduce the primary risk factor of Alzheimer\'s and how it may cause cognitive decline.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_633b076158bbc20001f5838d</guid> <xubDate>Mon, 03 Oct 2022 12:15:02 -0400</xubDate> <atom:updated>2022-10-04T03:52:16-04:00</atom:updated> <content:encoded>Recent discoveries in Alzheimer\'s disease research have thrown into question fundamental assumptions about the disease and its origins. In the second installment of this series, we introduce the primary risk factor of Alzheimer\'s and how it may cause cognitive decline.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b079b0dbd54e2b38286fd/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/633b079b0dbd54e2b38286fd/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/10/03/two-are-better-than-one-expanding-our-covid-19-vaccine-antigens/</link><title>Now.com Two Are Better Than One: Expanding Our Covid-19 Vaccine Antigens</title><description>Like influenza, SARS-CoV-2 is an expert at mutating and evading prior immunity. This includes vaccine-induced immunity. New research suggests that expanding the target area of our vaccines to include the virus\' nucleocapsid protein may offer stronger and broader protection. </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_63370d454b03040001eca142</guid> <xubDate>Mon, 03 Oct 2022 08:59:16 -0400</xubDate> <atom:updated>2022-10-04T03:52:12-04:00</atom:updated> <content:encoded>Like influenza, SARS-CoV-2 is an expert at mutating and evading prior immunity. This includes vaccine-induced immunity. New research suggests that expanding the target area of our vaccines to include the virus\' nucleocapsid protein may offer stronger and broader protection.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63370de5062d6726f44ce610/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63370de5062d6726f44ce610/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/30/covid-virus-accelerates-with-each-new-variant/</link><title>Now.com Covid Virus Accelerates With Each New Variant</title><description>As the SARS-CoV-2 virus continues to evolve, each new emerging variant is gaining growth advantages over its predecessor.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_633712f85327630001d3bea2</guid> <xubDate>Fri, 30 Sep 2022 12:07:44 -0400</xubDate> <atom:updated>2022-09-30T13:25:47-04:00</atom:updated> <content:encoded>As the SARS-CoV-2 virus continues to evolve, each new emerging variant is gaining growth advantages over its predecessor.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63371370f2cd8e77a0377b03/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63371370f2cd8e77a0377b03/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/29/cdc-study-says-isolating-in-a-separate-room-is-most-effective-against-household-transmission-of-sars-cov-2/</link><title>Now.com CDC: Keep Family From Catching Your Covid By Isolating In A Separate Room</title><description>A new CDC study shows that isolating in separate rooms significantly reduced the odds of SARS-CoV-2 transmission between household members.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6335ed554cf13b00016ef23b</guid> <xubDate>Thu, 29 Sep 2022 15:14:23 -0400</xubDate> <atom:updated>2022-09-30T08:47:17-04:00</atom:updated> <content:encoded>A new CDC study shows that isolating in separate rooms significantly reduced the odds of SARS-CoV-2 transmission between household members.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6335ee12872b2ea6488d051b/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6335ee12872b2ea6488d051b/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Editors\' Pick</category> <category domain="badge-slug">editors-pick</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/26/is-a-universal-influenza-vaccine--one-shot-for-all-strains--on-the-horizon/</link><title>Now.com Is A Universal Influenza Vaccine— One Shot For All Strains— On The Horizon?</title><description>Flu vaccines need to be readministered every year to keep pace with viral mutations. "Universal vaccines" could change this. Here, we describe a recent success in the development of a universal influenza A vaccine. </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6331a0141905c200019c1216</guid> <xubDate>Mon, 26 Sep 2022 10:13:47 -0400</xubDate> <atom:updated>2022-09-26T10:13:47-04:00</atom:updated> <content:encoded>Flu vaccines need to be readministered every year to keep pace with viral mutations. "Universal vaccines" could change this. Here, we describe a recent success in the development of a universal influenza A vaccine.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6331a5f25de424531fdd538d/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6331a5f25de424531fdd538d/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/22/waiting-in-the-wings-a-potential-new-variant-of-sars-cov-2/</link><title>Now.com Waiting In The Wings: A Potential New Variant Of SARS-CoV-2</title><description>A new member of the Omicron family, BA.2.75.2, shows potential as the next major variant of the Covid-19 pandemic.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_632b2e7537993c0001f9938f</guid> <xubDate>Thu, 22 Sep 2022 09:09:25 -0400</xubDate> <atom:updated>2022-09-23T03:38:29-04:00</atom:updated> <content:encoded>A new member of the Omicron family, BA.2.75.2, shows potential as the next major variant of the Covid-19 pandemic.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/632b2ea8d004622cdc7d2c23/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/632b2ea8d004622cdc7d2c23/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/21/sars-cov-2-main-protease-suppresses-innate-immunity-by-cleaving-proteins-required-for-interferon-induction-and-inflammation/</link><title>Now.com SARS-CoV-2 Main Protease Suppresses Innate Immunity By Cleaving Proteins Required For Interferon Induction And Inflammation</title><description>In addition to cleaving virus proteins, SARS-CoV-2 main protease released into the host cell has the potential to cleave cellular proteins.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_632b6f5854319d00015eb832</guid> <xubDate>Wed, 21 Sep 2022 16:30:15 -0400</xubDate> <atom:updated>2022-09-22T14:50:38-04:00</atom:updated> <content:encoded>In addition to cleaving virus proteins, SARS-CoV-2 main protease released into the host cell has the potential to cleave cellular proteins.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/632b6f79b5872b2488e7dad1/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/632b6f79b5872b2488e7dad1/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/19/getting-a-grip-on-influenza-the-pursuit-of-a-universal-vaccine-part-5/</link><title>Now.com Getting a Grip on Influenza: The Pursuit of a Universal Vaccine (Part 5)</title><description>Flu vaccines need to be readministered every year to keep pace with viral mutations. "Universal vaccines" could change this, providing us with a much broader immunity that remains effective even in the face of constant variation. How do they work? </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6324949503554c0001cbd631</guid> <xubDate>Mon, 19 Sep 2022 14:35:08 -0400</xubDate> <atom:updated>2022-09-21T17:19:27-04:00</atom:updated> <content:encoded>Flu vaccines need to be readministered every year to keep pace with viral mutations. "Universal vaccines" could change this, providing us with a much broader immunity that remains effective even in the face of constant variation. How do they work?</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6328ab8556e02f6a21de2903/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6328ab8556e02f6a21de2903/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/16/reimagining-alzheimers-part-1/</link><title>Now.com Reimagining Alzheimer’s (Part 1)</title><description>Recent discoveries in Alzheimer\'s disease research have thrown into question fundamental assumptions about the disease and its origins. In the first installment of our series, we offer a brief overview of Alzheimer\'s disease.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_63246a0f99f94c0001a24252</guid> <xubDate>Fri, 16 Sep 2022 13:53:10 -0400</xubDate> <atom:updated>2022-09-19T03:23:08-04:00</atom:updated> <content:encoded>Recent discoveries in Alzheimer\'s disease research have thrown into question fundamental assumptions about the disease and its origins. In the first installment of our series, we offer a brief overview of Alzheimer\'s disease.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63249784323bc02940065097/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63249784323bc02940065097/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/16/will-the-ba46-variant-drive-the-next-wave-of-the-covid-19-pandemic/</link><title>Now.com Will The BA.4.6 Variant Drive The Next Wave Of The Covid-19 Pandemic?</title><description>We draw attention to a variant, BA.4.6, which has the potential to trigger the next wave.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_632492f703554c0001cb2b3b</guid> <xubDate>Fri, 16 Sep 2022 12:42:38 -0400</xubDate> <atom:updated>2022-09-19T08:56:51-04:00</atom:updated> <content:encoded>We draw attention to a variant, BA.4.6, which has the potential to trigger the next wave.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6324a4908840859a677a03a7/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6324a4908840859a677a03a7/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/14/nasal-vaccines-may-not-be-the-game-changer-we-think-they-are/</link><title>Now.com Nasal Vaccines May Not Be The Game Changer We Think They Are</title><description>Many are pinning their hopes on nasal vaccines becoming the tool that finally halts transmission of the Covid-19 virus. I do not share the same unbridled enthusiasm that nasal vaccines will provide long-lasting protection from infection and protection from all variants for several reasons.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6322042b28dfc100014d58fe</guid> <xubDate>Wed, 14 Sep 2022 13:28:20 -0400</xubDate> <atom:updated>2022-09-15T03:38:39-04:00</atom:updated> <content:encoded>Many are pinning their hopes on nasal vaccines becoming the tool that finally halts transmission of the Covid-19 virus. I do not share the same unbridled enthusiasm that nasal vaccines will provide long-lasting protection from infection and protection from all variants for several reasons.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63220d504235def4ee45158a/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63220d504235def4ee45158a/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/14/molecular-jujitsu-sars-cov-2-co-opts-host-defense/</link><title>Now.com Molecular Jujitsu: SARS-CoV-2 Co-Opts Host Defense</title><description>A recent study shows how the SARS-CoV-2 N protein can co-opt a component of the host\'s defense to suppress host immunity</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_631771bea5948400018b3266</guid> <xubDate>Wed, 14 Sep 2022 11:59:46 -0400</xubDate> <atom:updated>2022-09-15T03:38:34-04:00</atom:updated> <content:encoded>A recent study shows how the SARS-CoV-2 N protein can co-opt a component of the host\'s defense to suppress host immunity</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6318991b29450c94d5d70388/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6318991b29450c94d5d70388/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/12/progress-in-the-search-for-broadly-neutralizing-monoclonal-antibodies-viii/</link><title>Now.com Progress In The Search For Broadly Neutralizing Monoclonal Antibodies VIII</title><description>The MO1 antibody strongly and broadly neutralizes SARS-CoV-2 variants, including the latest versions of Omicron - BA.5 and BA.2.75.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_631f336be8da520001c1b9a6</guid> <xubDate>Mon, 12 Sep 2022 09:33:08 -0400</xubDate> <atom:updated>2022-09-13T04:22:58-04:00</atom:updated> <content:encoded>The MO1 antibody strongly and broadly neutralizes SARS-CoV-2 variants, including the latest versions of Omicron - BA.5 and BA.2.75.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631f3458f8be59e00efe5866/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631f3458f8be59e00efe5866/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/07/getting-a-grip-on-influenza-the-pursuit-of-a-universal-vaccine-part-4/</link><title>Now.com Getting a Grip on Influenza: The Pursuit of a Universal Vaccine (Part 4)</title><description>Mucosal vaccines have been a source of a lot of excitement in recent years. How are they different from your usual flu vaccine, and are they more effective? </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6318af5f1867d60001419aeb</guid> <xubDate>Wed, 07 Sep 2022 12:55:16 -0400</xubDate> <atom:updated>2022-09-09T04:16:40-04:00</atom:updated> <content:encoded>Mucosal vaccines have been a source of a lot of excitement in recent years. How are they different from your usual flu vaccine, and are they more effective?</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6318aff6eed27d81b9d70386/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6318aff6eed27d81b9d70386/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/06/progress-in-the-search-for-broadly-neutralizing-monoclonal-antibodies-vii/</link><title>Now.com Progress In The Search For Broadly Neutralizing Monoclonal Antibodies VII</title><description>The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_63174d54a5948400017fd0c8</guid> <xubDate>Tue, 06 Sep 2022 09:48:17 -0400</xubDate> <atom:updated>2022-09-08T07:35:38-04:00</atom:updated> <content:encoded>The P2G3 antibody is the latest in a long line of potential SARS-CoV-2 monoclonal antibody treatments to neutralize a broad range of viral variants.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63174d6d03ac262ead352194/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63174d6d03ac262ead352194/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/02/covid-19-infection-increases-risk-and-excess-burden-of-cardiovascular-disease/</link><title>Now.com Covid-19 Infection Increases Risk And Excess Burden Of Cardiovascular Disease</title><description>A study demonstrates that infection with Covid-19 impacts the risk of cardiovascular events up to 12 months post-infection, regardless of age, race, sex, and other cardiovascular risk factors.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6312436eeefaa20001dc9996</guid> <xubDate>Fri, 02 Sep 2022 14:11:54 -0400</xubDate> <atom:updated>2022-09-05T21:51:49-04:00</atom:updated> <content:encoded>A study demonstrates that infection with Covid-19 impacts the risk of cardiovascular events up to 12 months post-infection, regardless of age, race, sex, and other cardiovascular risk factors.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631246feb64137a0fedbaac6/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631246feb64137a0fedbaac6/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/02/long-covid-is-keeping-millions-of-people-out-of-work/</link><title>Now.com Long Covid Is Keeping Millions Of People Out Of Work</title><description>A new Brookings report finds that Long Covid is keeping as many as 4 million people out of work.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_631215483358270001af17a0</guid> <xubDate>Fri, 02 Sep 2022 12:51:23 -0400</xubDate> <atom:updated>2022-09-05T21:52:06-04:00</atom:updated> <content:encoded>A new Brookings report finds that Long Covid is keeping as many as 4 million people out of work.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631232934220a3347b2931db/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/631232934220a3347b2931db/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/02/hopeful-new-entry-in-the-race-for-a-universal-covid-vaccine/</link><title>Now.com Hopeful New Entry In The Race For A Universal Covid Vaccine</title><description>A Swedish research team suggests their vaccine candidate may protect against many SARS-Cov-2 variants.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6311f81433582700018e3275</guid> <xubDate>Fri, 02 Sep 2022 08:55:06 -0400</xubDate> <atom:updated>2022-09-05T21:57:08-04:00</atom:updated> <content:encoded>A Swedish research team suggests their vaccine candidate may protect against many SARS-Cov-2 variants.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6311f9d5b36e904385515c93/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6311f9d5b36e904385515c93/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/01/progress-in-the-search-for-broadly-neutralizing-monoclonal-antibodies-vi/</link><title>Now.com Progress In The Search For Broadly Neutralizing Monoclonal Antibodies VI</title><description>These latest broadly neutralizing monoclonal antibodies not only overcome major Omicron strains, but many other related coronaviruses as well.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_6310b5f22bd7720001ae5216</guid> <xubDate>Thu, 01 Sep 2022 09:44:56 -0400</xubDate> <atom:updated>2022-09-07T13:04:11-04:00</atom:updated> <content:encoded>These latest broadly neutralizing monoclonal antibodies not only overcome major Omicron strains, but many other related coronaviruses as well.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6310b647df76eb2dfde4f55d/0x0.jpg?width=960&amp;precrop=1272%2C715%2Cx0%2Cy0" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6310b647df76eb2dfde4f55d/0x0.jpg?width=960&amp;precrop=1272%2C715%2Cx0%2Cy0"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/09/01/five-days-is-too-short-study-says-to-end-covid-19-isolation-based-on-rapid-tests-results-instead/</link><title>Now.com Five Days Is Too Short! Study Says To End Covid-19 Isolation Based On Rapid Tests Results Instead</title><description>A study from the Imperial College of London suggests that people with Covid-19 should isolate themselves for a minimum of five days and safely exit depending on rapid antigen test results. </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_630d2d68f431740001d6ce58</guid> <xubDate>Thu, 01 Sep 2022 08:15:17 -0400</xubDate> <atom:updated>2022-09-02T03:45:21-04:00</atom:updated> <content:encoded>A study from the Imperial College of London suggests that people with Covid-19 should isolate themselves for a minimum of five days and safely exit depending on rapid antigen test results.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/630e0f3239b23d881bff61b1/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/630e0f3239b23d881bff61b1/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/08/29/increased-disease-potential-of-covid-variant-ba5-currently-circulating-in-the-united-states/</link><title>Now.com Increased Disease Potential Of Covid Variant BA.5 Currently Circulating In The United States</title><description>BA.5, the leading variant in the United States, contains intrinsic virological properties that give it an edge over other variants.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_630cb8ae3307610001c36797</guid> <xubDate>Mon, 29 Aug 2022 09:06:41 -0400</xubDate> <atom:updated>2022-09-01T03:38:47-04:00</atom:updated> <content:encoded>BA.5, the leading variant in the United States, contains intrinsic virological properties that give it an edge over other variants.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/630cb8dfa4cebfad2b8414d4/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/630cb8dfa4cebfad2b8414d4/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="badge-name">Coronavirus</category> <category domain="badge-slug">coronavirus</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/08/29/getting-a-grip-on-influenza-the-pursuit-of-a-universal-vaccine-part-3/</link><title>Now.com Getting a Grip on Influenza: The Pursuit of a Universal Vaccine (Part 3)</title><description>mRNA vaccine technology rose to prominence during the Covid-19 pandemic. But the same system can be used to combat other viruses, with the promise of quicker turnaround and cheaper manufacturing. Will the next influenza vaccine be an mRNA vaccine? </description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_63063543d8e21f0001b0a6a2</guid> <xubDate>Mon, 29 Aug 2022 08:51:54 -0400</xubDate> <atom:updated>2022-09-01T03:38:47-04:00</atom:updated> <content:encoded>mRNA vaccine technology rose to prominence during the Covid-19 pandemic. But the same system can be used to combat other viruses, with the promise of quicker turnaround and cheaper manufacturing. Will the next influenza vaccine be an mRNA vaccine?</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6308c592fb2e332a0a1b5fd3/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/6308c592fb2e332a0a1b5fd3/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item><item><link>https://www.xn--nw-8bb.com/sites/williamhaseltine/2022/08/26/the-heavy-lifting-of-t-cells-in-immunocompromised-covid-19-patients/</link><title>Now.com T Cells Play An Important Role In Immunity, But Without B Cells Cannot Provide Protection From Covid-19</title><description>A study published in the journal Viruses seeks to understand what happens to T cell responses if the B cell defense of adaptive immunity is severely compromised.</description> <dc:creator>William A. Haseltine, Contributor</dc:creator> <atom:author> <atom:name>William A. Haseltine, Contributor</atom:name> <atom:uri>https://www.xn--nw-8bb.com/sites/williamhaseltine/</atom:uri> </atom:author> <guid isPermaLink="false">content_63063540d8e21f0001b0a4c6</guid> <xubDate>Fri, 26 Aug 2022 14:19:14 -0400</xubDate> <atom:updated>2022-08-29T09:08:02-04:00</atom:updated> <content:encoded>A study published in the journal Viruses seeks to understand what happens to T cell responses if the B cell defense of adaptive immunity is severely compromised.</content:encoded> <media:content url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63079fcd026c9f7223515cb1/0x0.jpg?width=960" medium="image"> <media:thumbnail url="https://imageio.xn--nw-8bb.com/specials-images/imageserve/63079fcd026c9f7223515cb1/0x0.jpg?width=960"/> </media:content> <category domain="primary-channel-section">Healthcare</category> <category domain="primary-channel-link">/healthcare</category> <category domain="channel-section">Innovation</category> <category domain="channel-link">/innovation</category> <category domain="channel-section">Healthcare</category> <category domain="channel-link">/healthcare</category> <category domain="display-channel">business</category> <category domain="display-section">pharma &amp; healthcare</category>
</item></channel></rss>')); ?>